Breast Cancer News

Dr. Hope Rugo comments on study results that suggest biomarkers can predict trastuzumab resistance and lapatinib response in breast cancer. Kerri Wachter of Elsevier Global Medical News (

Duration : 0:3:4

Read the rest of this entry »

Technorati Tags: breast, cancer, EGMN, elsevier, global, lapatinib, medical, News, rugo, trastuzumab, wachter

Dr. Hope Rugo comments on study results that suggest biomarkers can predict trastuzumab resistance and lapatinib response in breast cancer. Kerri Wachter of Elsevier Global Medical News (EGMN) reports from the annual San Antonio Breast Cancer Symposium.

Duration : 0:3:4

Read the rest of this entry »

Technorati Tags: breast, cancer, EGMN, elsevier, global, lapatinib, medical, News, rugo, trastuzumab, wachter

Dr. Hope Rugo comments on study results that suggest biomarkers can predict trastuzumab resistance and lapatinib response in breast cancer. Kerri Wachter of Elsevier Global Medical News (EGMN) reports from the annual San Antonio Breast Cancer Symposium.

Duration : 0:3:4

Read the rest of this entry »

Technorati Tags: breast, cancer, EGMN, elsevier, global, lapatinib, medical, News, rugo, trastuzumab, wachter

Dr. Hope Rugo comments on study results that suggest biomarkers can predict trastuzumab resistance and lapatinib response in breast cancer. Kerri Wachter of Elsevier Global Medical News (EGMN) reports from the annual San Antonio Breast Cancer Symposium.

Duration : 0:3:4

Read the rest of this entry »

Technorati Tags: breast, cancer, EGMN, elsevier, global, lapatinib, medical, News, rugo, trastuzumab, wachter

Dr. Hope Rugo comments on study results that suggest biomarkers can predict trastuzumab resistance and lapatinib response in breast cancer. Kerri Wachter of Elsevier Global Medical News (EGMN) reports from the annual San Antonio Breast Cancer Symposium.

Duration : 0:3:4

Read the rest of this entry »

Technorati Tags: breast, cancer, EGMN, elsevier, global, lapatinib, medical, News, rugo, trastuzumab, wachter